Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

NCT02097004 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

BIOLOGICAL: Peginterferon alfa-2a
BIOLOGICAL: HBV vaccination
DRUG: Entecavir

Sponsor

Seoul National University Hospital